Tenax Therapeutics Inc (TENX)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -91.198 | -53.203 | -121.784 | -85.21 | -34.954 | -115.995 | -235.139 | -102.2 |
Return on Equity (%) | -113.259 | -67.94 | -136.968 | -108.01 | -36.64 | -119.731 | -385.082 | -160.797 |
Return on Invested Capital (%) | -79.352 | -126.874 | -73.225 | -110.195 | -524.283 | -1544.867 | -386.469 | -171.9 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.61 | 6.29 | 1.771 | 0.556 | 3.95 | 0.168 | 0.05 | 0.339 |
Earnings Per Share | -1.562 | -6.261 | -2.128 | -1.238 | -0.778 | -1.286 | -0.368 | -0.323 |
Cash Per Share | 0.355 | 1.137 | 1.861 | 0.723 | N/A | 0.221 | 0.071 | 0.41 |
Working Capital Per Share | 0.264 | 4.996 | 1.769 | 0.538 | N/A | 0.163 | 0.045 | 0.339 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -1.845 | -6.261 | -1.025 | -1.238 | -0.778 | -1.286 | -0.368 | -0.323 |
EBITDA Per Share | -1.845 | -6.261 | -1.025 | -1.238 | -0.778 | -1.286 | -0.368 | -0.323 |
Free Cash Flow Per Share | -1.563 | -6.267 | -2.128 | -1.238 | -0.778 | -1.286 | -0.368 | -0.323 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 28.12M | 1.41M | 3.79M | 6.74M | 12.62M | 25.21M | N/A | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 18.71M |
Price to Earnings Ratio | -2.43 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 1.91 |
Price to Book Ratio | 2.31 |
Dividend Yield | - |
Shares Outstanding | 3.41M |
Average Volume (1 week) | 20.91k |
Average Volume (1 Month) | 62.49k |
52 Week Change | -77.83% |
52 Week High | 27.3272 |
52 Week Low | 2.77 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.